CN113481189B - Sucrose isomerase mutant and application thereof - Google Patents
Sucrose isomerase mutant and application thereof Download PDFInfo
- Publication number
- CN113481189B CN113481189B CN202110868362.2A CN202110868362A CN113481189B CN 113481189 B CN113481189 B CN 113481189B CN 202110868362 A CN202110868362 A CN 202110868362A CN 113481189 B CN113481189 B CN 113481189B
- Authority
- CN
- China
- Prior art keywords
- leu
- asp
- asn
- ala
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010047540 sucrose isomerase Proteins 0.000 title claims abstract description 64
- 238000006243 chemical reaction Methods 0.000 claims abstract description 49
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims abstract description 31
- 102000004190 Enzymes Human genes 0.000 claims abstract description 31
- 108090000790 Enzymes Proteins 0.000 claims abstract description 31
- 230000000694 effects Effects 0.000 claims abstract description 24
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 23
- 229930006000 Sucrose Natural products 0.000 claims abstract description 23
- 239000005720 sucrose Substances 0.000 claims abstract description 23
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 3
- 239000000758 substrate Substances 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 108010093096 Immobilized Enzymes Proteins 0.000 abstract description 24
- 238000000855 fermentation Methods 0.000 abstract description 7
- 230000004151 fermentation Effects 0.000 abstract description 7
- 230000035772 mutation Effects 0.000 abstract description 6
- 239000012535 impurity Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 241000611870 Pantoea dispersa Species 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 239000008055 phosphate buffer solution Substances 0.000 description 6
- 230000009465 prokaryotic expression Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 5
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 4
- ZTLGVASZOIKNIX-DCAQKATOSA-N Leu-Gln-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZTLGVASZOIKNIX-DCAQKATOSA-N 0.000 description 4
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 4
- 108010077245 asparaginyl-proline Proteins 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000011426 transformation method Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000520272 Pantoea Species 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- MKZCBYZBCINNJN-DLOVCJGASA-N Ala-Asp-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MKZCBYZBCINNJN-DLOVCJGASA-N 0.000 description 2
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 2
- FBHOPGDGELNWRH-DRZSPHRISA-N Ala-Glu-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FBHOPGDGELNWRH-DRZSPHRISA-N 0.000 description 2
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 2
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 2
- JAQNUEWEJWBVAY-WBAXXEDZSA-N Ala-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 JAQNUEWEJWBVAY-WBAXXEDZSA-N 0.000 description 2
- JNLDTVRGXMSYJC-UVBJJODRSA-N Ala-Pro-Trp Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O JNLDTVRGXMSYJC-UVBJJODRSA-N 0.000 description 2
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 2
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 2
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 2
- JPOQZCHGOTWRTM-FQPOAREZSA-N Ala-Tyr-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPOQZCHGOTWRTM-FQPOAREZSA-N 0.000 description 2
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 2
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 2
- VNFWDYWTSHFRRG-SRVKXCTJSA-N Arg-Gln-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O VNFWDYWTSHFRRG-SRVKXCTJSA-N 0.000 description 2
- LMPKCSXZJSXBBL-NHCYSSNCSA-N Arg-Gln-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O LMPKCSXZJSXBBL-NHCYSSNCSA-N 0.000 description 2
- GOWZVQXTHUCNSQ-NHCYSSNCSA-N Arg-Glu-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GOWZVQXTHUCNSQ-NHCYSSNCSA-N 0.000 description 2
- OCDJOVKIUJVUMO-SRVKXCTJSA-N Arg-His-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N OCDJOVKIUJVUMO-SRVKXCTJSA-N 0.000 description 2
- NOZYDJOPOGKUSR-AVGNSLFASA-N Arg-Leu-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O NOZYDJOPOGKUSR-AVGNSLFASA-N 0.000 description 2
- GRRXPUAICOGISM-RWMBFGLXSA-N Arg-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GRRXPUAICOGISM-RWMBFGLXSA-N 0.000 description 2
- KSUALAGYYLQSHJ-RCWTZXSCSA-N Arg-Met-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KSUALAGYYLQSHJ-RCWTZXSCSA-N 0.000 description 2
- XFXZKCRBBOVJKS-BVSLBCMMSA-N Arg-Phe-Trp Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 XFXZKCRBBOVJKS-BVSLBCMMSA-N 0.000 description 2
- KXOPYFNQLVUOAQ-FXQIFTODSA-N Arg-Ser-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KXOPYFNQLVUOAQ-FXQIFTODSA-N 0.000 description 2
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 2
- QUBKBPZGMZWOKQ-SZMVWBNQSA-N Arg-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 QUBKBPZGMZWOKQ-SZMVWBNQSA-N 0.000 description 2
- LOVIQNMIPQVIGT-BVSLBCMMSA-N Arg-Trp-Phe Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCCN=C(N)N)N)C(O)=O)C1=CC=CC=C1 LOVIQNMIPQVIGT-BVSLBCMMSA-N 0.000 description 2
- YNDLOUMBVDVALC-ZLUOBGJFSA-N Asn-Ala-Ala Chemical compound C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)N YNDLOUMBVDVALC-ZLUOBGJFSA-N 0.000 description 2
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 2
- UDSVWSUXKYXSTR-QWRGUYRKSA-N Asn-Gly-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UDSVWSUXKYXSTR-QWRGUYRKSA-N 0.000 description 2
- KMCRKVOLRCOMBG-DJFWLOJKSA-N Asn-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N KMCRKVOLRCOMBG-DJFWLOJKSA-N 0.000 description 2
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 2
- GIQCDTKOIPUDSG-GARJFASQSA-N Asn-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N)C(=O)O GIQCDTKOIPUDSG-GARJFASQSA-N 0.000 description 2
- JTXVXGXTRXMOFJ-FXQIFTODSA-N Asn-Pro-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O JTXVXGXTRXMOFJ-FXQIFTODSA-N 0.000 description 2
- GFGUPLIETCNQGF-DCAQKATOSA-N Asn-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O GFGUPLIETCNQGF-DCAQKATOSA-N 0.000 description 2
- OOXUBGLNDRGOKT-FXQIFTODSA-N Asn-Ser-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OOXUBGLNDRGOKT-FXQIFTODSA-N 0.000 description 2
- XZFONYMRYTVLPL-NHCYSSNCSA-N Asn-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N XZFONYMRYTVLPL-NHCYSSNCSA-N 0.000 description 2
- OERMIMJQPQUIPK-FXQIFTODSA-N Asp-Arg-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O OERMIMJQPQUIPK-FXQIFTODSA-N 0.000 description 2
- MFMJRYHVLLEMQM-DCAQKATOSA-N Asp-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N MFMJRYHVLLEMQM-DCAQKATOSA-N 0.000 description 2
- ILJQISGMGXRZQQ-IHRRRGAJSA-N Asp-Arg-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ILJQISGMGXRZQQ-IHRRRGAJSA-N 0.000 description 2
- UGIBTKGQVWFTGX-BIIVOSGPSA-N Asp-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O UGIBTKGQVWFTGX-BIIVOSGPSA-N 0.000 description 2
- PSLSTUMPZILTAH-BYULHYEWSA-N Asp-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PSLSTUMPZILTAH-BYULHYEWSA-N 0.000 description 2
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 2
- SPKCGKRUYKMDHP-GUDRVLHUSA-N Asp-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N SPKCGKRUYKMDHP-GUDRVLHUSA-N 0.000 description 2
- KLYPOCBLKMPBIQ-GHCJXIJMSA-N Asp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N KLYPOCBLKMPBIQ-GHCJXIJMSA-N 0.000 description 2
- CLUMZOKVGUWUFD-CIUDSAMLSA-N Asp-Leu-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O CLUMZOKVGUWUFD-CIUDSAMLSA-N 0.000 description 2
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 2
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 2
- HCOQNGIHSXICCB-IHRRRGAJSA-N Asp-Tyr-Arg Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)O HCOQNGIHSXICCB-IHRRRGAJSA-N 0.000 description 2
- 108010083946 Asp-Tyr-Leu-Lys Proteins 0.000 description 2
- BYLPQJAWXJWUCJ-YDHLFZDLSA-N Asp-Tyr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O BYLPQJAWXJWUCJ-YDHLFZDLSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000010911 Enzyme Precursors Human genes 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 2
- HHWQMFIGMMOVFK-WDSKDSINSA-N Gln-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O HHWQMFIGMMOVFK-WDSKDSINSA-N 0.000 description 2
- IVCOYUURLWQDJQ-LPEHRKFASA-N Gln-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O IVCOYUURLWQDJQ-LPEHRKFASA-N 0.000 description 2
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 2
- JKGHMESJHRTHIC-SIUGBPQLSA-N Gln-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JKGHMESJHRTHIC-SIUGBPQLSA-N 0.000 description 2
- QBLMTCRYYTVUQY-GUBZILKMSA-N Gln-Leu-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QBLMTCRYYTVUQY-GUBZILKMSA-N 0.000 description 2
- IULKWYSYZSURJK-AVGNSLFASA-N Gln-Leu-Lys Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O IULKWYSYZSURJK-AVGNSLFASA-N 0.000 description 2
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 2
- SFAFZYYMAWOCIC-KKUMJFAQSA-N Gln-Phe-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SFAFZYYMAWOCIC-KKUMJFAQSA-N 0.000 description 2
- VNTGPISAOMAXRK-CIUDSAMLSA-N Gln-Pro-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O VNTGPISAOMAXRK-CIUDSAMLSA-N 0.000 description 2
- RNPGPFAVRLERPP-QEJZJMRPSA-N Gln-Trp-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O RNPGPFAVRLERPP-QEJZJMRPSA-N 0.000 description 2
- HPBKQFJXDUVNQV-FHWLQOOXSA-N Gln-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O HPBKQFJXDUVNQV-FHWLQOOXSA-N 0.000 description 2
- SDSMVVSHLAAOJL-UKJIMTQDSA-N Gln-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N SDSMVVSHLAAOJL-UKJIMTQDSA-N 0.000 description 2
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 2
- OPAINBJQDQTGJY-JGVFFNPUSA-N Glu-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)O)N)C(=O)O OPAINBJQDQTGJY-JGVFFNPUSA-N 0.000 description 2
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 2
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 2
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 2
- NPMSEUWUMOSEFM-CIUDSAMLSA-N Glu-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N NPMSEUWUMOSEFM-CIUDSAMLSA-N 0.000 description 2
- LHIPZASLKPYDPI-AVGNSLFASA-N Glu-Phe-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LHIPZASLKPYDPI-AVGNSLFASA-N 0.000 description 2
- NTHIHAUEXVTXQG-KKUMJFAQSA-N Glu-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O NTHIHAUEXVTXQG-KKUMJFAQSA-N 0.000 description 2
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 description 2
- CQZDZKRHFWJXDF-WDSKDSINSA-N Gly-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CN CQZDZKRHFWJXDF-WDSKDSINSA-N 0.000 description 2
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 2
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 2
- FHQRLHFYVZAQHU-IUCAKERBSA-N Gly-Lys-Gln Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O FHQRLHFYVZAQHU-IUCAKERBSA-N 0.000 description 2
- JKSMZVCGQWVTBW-STQMWFEESA-N Gly-Trp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O JKSMZVCGQWVTBW-STQMWFEESA-N 0.000 description 2
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 2
- SBVMXEZQJVUARN-XPUUQOCRSA-N Gly-Val-Ser Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O SBVMXEZQJVUARN-XPUUQOCRSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- WZOGEMJIZBNFBK-CIUDSAMLSA-N His-Asp-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O WZOGEMJIZBNFBK-CIUDSAMLSA-N 0.000 description 2
- UWSMZKRTOZEGDD-CUJWVEQBSA-N His-Thr-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O UWSMZKRTOZEGDD-CUJWVEQBSA-N 0.000 description 2
- DLTCGJZBNFOWFL-LKTVYLICSA-N His-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CN=CN2)N DLTCGJZBNFOWFL-LKTVYLICSA-N 0.000 description 2
- DPTBVFUDCPINIP-JURCDPSOSA-N Ile-Ala-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DPTBVFUDCPINIP-JURCDPSOSA-N 0.000 description 2
- XENGULNPUDGALZ-ZPFDUUQYSA-N Ile-Asn-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N XENGULNPUDGALZ-ZPFDUUQYSA-N 0.000 description 2
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 2
- IITVUURPOYGCTD-NAKRPEOUSA-N Ile-Pro-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IITVUURPOYGCTD-NAKRPEOUSA-N 0.000 description 2
- XVUAQNRNFMVWBR-BLMTYFJBSA-N Ile-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N XVUAQNRNFMVWBR-BLMTYFJBSA-N 0.000 description 2
- ZUWSVOYKBCHLRR-MGHWNKPDSA-N Ile-Tyr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZUWSVOYKBCHLRR-MGHWNKPDSA-N 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 2
- ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 2
- MYGQXVYRZMKRDB-SRVKXCTJSA-N Leu-Asp-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN MYGQXVYRZMKRDB-SRVKXCTJSA-N 0.000 description 2
- HMDDEJADNKQTBR-BZSNNMDCSA-N Leu-His-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMDDEJADNKQTBR-BZSNNMDCSA-N 0.000 description 2
- AVEGDIAXTDVBJS-XUXIUFHCSA-N Leu-Ile-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AVEGDIAXTDVBJS-XUXIUFHCSA-N 0.000 description 2
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 2
- BMVFXOQHDQZAQU-DCAQKATOSA-N Leu-Pro-Asp Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N BMVFXOQHDQZAQU-DCAQKATOSA-N 0.000 description 2
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 2
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 2
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 2
- DEFGUIIUYAUEDU-ZPFDUUQYSA-N Lys-Asn-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DEFGUIIUYAUEDU-ZPFDUUQYSA-N 0.000 description 2
- KPJJOZUXFOLGMQ-CIUDSAMLSA-N Lys-Asp-Asn Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N KPJJOZUXFOLGMQ-CIUDSAMLSA-N 0.000 description 2
- YVMQJGWLHRWMDF-MNXVOIDGSA-N Lys-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N YVMQJGWLHRWMDF-MNXVOIDGSA-N 0.000 description 2
- HEWWNLVEWBJBKA-WDCWCFNPSA-N Lys-Gln-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN HEWWNLVEWBJBKA-WDCWCFNPSA-N 0.000 description 2
- ODUQLUADRKMHOZ-JYJNAYRXSA-N Lys-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)O ODUQLUADRKMHOZ-JYJNAYRXSA-N 0.000 description 2
- CBNMHRCLYBJIIZ-XUXIUFHCSA-N Lys-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCCN)N CBNMHRCLYBJIIZ-XUXIUFHCSA-N 0.000 description 2
- VSTNAUBHKQPVJX-IHRRRGAJSA-N Lys-Met-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O VSTNAUBHKQPVJX-IHRRRGAJSA-N 0.000 description 2
- XFANQCRHTMOEAP-WDSOQIARSA-N Lys-Pro-Trp Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O XFANQCRHTMOEAP-WDSOQIARSA-N 0.000 description 2
- IMDJSVBFQKDDEQ-MGHWNKPDSA-N Lys-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)N IMDJSVBFQKDDEQ-MGHWNKPDSA-N 0.000 description 2
- OHXUUQDOBQKSNB-AVGNSLFASA-N Lys-Val-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OHXUUQDOBQKSNB-AVGNSLFASA-N 0.000 description 2
- DRXODWRPPUFIAY-DCAQKATOSA-N Met-Asn-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN DRXODWRPPUFIAY-DCAQKATOSA-N 0.000 description 2
- WYDFQSJOARJAMM-GUBZILKMSA-N Met-Pro-Asp Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WYDFQSJOARJAMM-GUBZILKMSA-N 0.000 description 2
- RIIFMEBFDDXGCV-VEVYYDQMSA-N Met-Thr-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O RIIFMEBFDDXGCV-VEVYYDQMSA-N 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 2
- QMMRHASQEVCJGR-UBHSHLNASA-N Phe-Ala-Pro Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 QMMRHASQEVCJGR-UBHSHLNASA-N 0.000 description 2
- SWZKMTDPQXLQRD-XVSYOHENSA-N Phe-Asp-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWZKMTDPQXLQRD-XVSYOHENSA-N 0.000 description 2
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 2
- VADLTGVIOIOKGM-BZSNNMDCSA-N Phe-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CN=CN1 VADLTGVIOIOKGM-BZSNNMDCSA-N 0.000 description 2
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 2
- BNRFQGLWLQESBG-YESZJQIVSA-N Phe-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O BNRFQGLWLQESBG-YESZJQIVSA-N 0.000 description 2
- NJONQBYLTANINY-IHPCNDPISA-N Phe-Trp-Asn Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(O)=O NJONQBYLTANINY-IHPCNDPISA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- HPXVFFIIGOAQRV-DCAQKATOSA-N Pro-Arg-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O HPXVFFIIGOAQRV-DCAQKATOSA-N 0.000 description 2
- CYQQWUPHIZVCNY-GUBZILKMSA-N Pro-Arg-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CYQQWUPHIZVCNY-GUBZILKMSA-N 0.000 description 2
- WWAQEUOYCYMGHB-FXQIFTODSA-N Pro-Asn-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 WWAQEUOYCYMGHB-FXQIFTODSA-N 0.000 description 2
- SWXSLPHTJVAWDF-VEVYYDQMSA-N Pro-Asn-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWXSLPHTJVAWDF-VEVYYDQMSA-N 0.000 description 2
- WPQKSRHDTMRSJM-CIUDSAMLSA-N Pro-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 WPQKSRHDTMRSJM-CIUDSAMLSA-N 0.000 description 2
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 2
- ODPIUQVTULPQEP-CIUDSAMLSA-N Pro-Gln-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]1CCCN1 ODPIUQVTULPQEP-CIUDSAMLSA-N 0.000 description 2
- XQSREVQDGCPFRJ-STQMWFEESA-N Pro-Gly-Phe Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XQSREVQDGCPFRJ-STQMWFEESA-N 0.000 description 2
- IBGCFJDLCYTKPW-NAKRPEOUSA-N Pro-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 IBGCFJDLCYTKPW-NAKRPEOUSA-N 0.000 description 2
- ZTMLZUNPFDGPKY-VKOGCVSHSA-N Pro-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@@H]3CCCN3 ZTMLZUNPFDGPKY-VKOGCVSHSA-N 0.000 description 2
- QKDIHFHGHBYTKB-IHRRRGAJSA-N Pro-Ser-Phe Chemical compound N([C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 QKDIHFHGHBYTKB-IHRRRGAJSA-N 0.000 description 2
- KWMZPPWYBVZIER-XGEHTFHBSA-N Pro-Ser-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWMZPPWYBVZIER-XGEHTFHBSA-N 0.000 description 2
- ZYJMLBCDFPIGNL-JYJNAYRXSA-N Pro-Tyr-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O ZYJMLBCDFPIGNL-JYJNAYRXSA-N 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- IDCKUIWEIZYVSO-WFBYXXMGSA-N Ser-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C)C(O)=O)=CNC2=C1 IDCKUIWEIZYVSO-WFBYXXMGSA-N 0.000 description 2
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 2
- KJMOINFQVCCSDX-XKBZYTNZSA-N Ser-Gln-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KJMOINFQVCCSDX-XKBZYTNZSA-N 0.000 description 2
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 2
- MOQDPPUMFSMYOM-KKUMJFAQSA-N Ser-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CO)N MOQDPPUMFSMYOM-KKUMJFAQSA-N 0.000 description 2
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 2
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 2
- UGGWCAFQPKANMW-FXQIFTODSA-N Ser-Met-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O UGGWCAFQPKANMW-FXQIFTODSA-N 0.000 description 2
- WNDUPCKKKGSKIQ-CIUDSAMLSA-N Ser-Pro-Gln Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O WNDUPCKKKGSKIQ-CIUDSAMLSA-N 0.000 description 2
- OSFZCEQJLWCIBG-BZSNNMDCSA-N Ser-Tyr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OSFZCEQJLWCIBG-BZSNNMDCSA-N 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- UHBPFYOQQPFKQR-JHEQGTHGSA-N Thr-Gln-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O UHBPFYOQQPFKQR-JHEQGTHGSA-N 0.000 description 2
- WYLAVUAWOUVUCA-XVSYOHENSA-N Thr-Phe-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WYLAVUAWOUVUCA-XVSYOHENSA-N 0.000 description 2
- BDENGIGFTNYZSJ-RCWTZXSCSA-N Thr-Pro-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(O)=O BDENGIGFTNYZSJ-RCWTZXSCSA-N 0.000 description 2
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 2
- TZNNEYFZZAHLBL-BPUTZDHNSA-N Trp-Arg-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O TZNNEYFZZAHLBL-BPUTZDHNSA-N 0.000 description 2
- HYNAKPYFEYJMAS-XIRDDKMYSA-N Trp-Arg-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HYNAKPYFEYJMAS-XIRDDKMYSA-N 0.000 description 2
- UPNRACRNHISCAF-SZMVWBNQSA-N Trp-Lys-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 UPNRACRNHISCAF-SZMVWBNQSA-N 0.000 description 2
- HTGJDTPQYFMKNC-VFAJRCTISA-N Trp-Thr-Leu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)[C@@H](C)O)=CNC2=C1 HTGJDTPQYFMKNC-VFAJRCTISA-N 0.000 description 2
- JRXKIVGWMMIIOF-YDHLFZDLSA-N Tyr-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N JRXKIVGWMMIIOF-YDHLFZDLSA-N 0.000 description 2
- NLMXVDDEQFKQQU-CFMVVWHZSA-N Tyr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLMXVDDEQFKQQU-CFMVVWHZSA-N 0.000 description 2
- ZRPLVTZTKPPSBT-AVGNSLFASA-N Tyr-Glu-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZRPLVTZTKPPSBT-AVGNSLFASA-N 0.000 description 2
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 2
- RCMWNNJFKNDKQR-UFYCRDLUSA-N Tyr-Pro-Phe Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 RCMWNNJFKNDKQR-UFYCRDLUSA-N 0.000 description 2
- TYGHOWWWMTWVKM-HJOGWXRNSA-N Tyr-Tyr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 TYGHOWWWMTWVKM-HJOGWXRNSA-N 0.000 description 2
- YFOCMOVJBQDBCE-NRPADANISA-N Val-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N YFOCMOVJBQDBCE-NRPADANISA-N 0.000 description 2
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 2
- QPZMOUMNTGTEFR-ZKWXMUAHSA-N Val-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N QPZMOUMNTGTEFR-ZKWXMUAHSA-N 0.000 description 2
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 2
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 2
- BZMIYHIJVVJPCK-QSFUFRPTSA-N Val-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N BZMIYHIJVVJPCK-QSFUFRPTSA-N 0.000 description 2
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 2
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 2
- 108010041407 alanylaspartic acid Proteins 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 2
- 108010094001 arginyl-tryptophyl-arginine Proteins 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 2
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 108010078274 isoleucylvaline Proteins 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 108010012058 leucyltyrosine Proteins 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 108010084525 phenylalanyl-phenylalanyl-glycine Proteins 0.000 description 2
- 108010073101 phenylalanylleucine Proteins 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 2
- 108010045269 tryptophyltryptophan Proteins 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- 108010077037 tyrosyl-tyrosyl-phenylalanine Proteins 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- SVBWNHOBPFJIRU-UHFFFAOYSA-N 1-O-alpha-D-Glucopyranosyl-D-fructose Natural products OC1C(O)C(O)C(CO)OC1OCC1(O)C(O)C(O)C(O)CO1 SVBWNHOBPFJIRU-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- XLZCLJRGGMBKLR-PCBIJLKTSA-N Asn-Ile-Phe Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XLZCLJRGGMBKLR-PCBIJLKTSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 1
- 108010033128 Glucan Endo-1,3-beta-D-Glucosidase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 101150049452 SIM gene Proteins 0.000 description 1
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 1
- PJIQEIFXZPCWOJ-FXQIFTODSA-N Ser-Pro-Asp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O PJIQEIFXZPCWOJ-FXQIFTODSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- NMXLJRHBJVMYPD-IPFGBZKGSA-N trehalulose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NMXLJRHBJVMYPD-IPFGBZKGSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/99—Intramolecular transferases (5.4) transferring other groups (5.4.99)
- C12Y504/99011—Isomaltulose synthase (5.4.99.11)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of enzyme engineering, and relates to a sucrose isomerase mutant and application thereof. The mutant has the mutations of R434P and E273N in the wild sucrose isomerase of the amino acid sequence shown in SEQ ID NO. 1. Compared with the wild sucrose isomerase, the mutant has obviously improved thermal stability and fermentation activity. The immobilized enzyme prepared by the mutant has higher activity, obviously increased stability, improved sucrose conversion rate and isomaltulose generation rate, lower impurity content and is more suitable for industrial application.
Description
Technical Field
The invention belongs to the technical field of enzyme engineering, and relates to a sucrose isomerase mutant and application thereof.
Background
Sucrose isomerase (EC 5.4.99.11) is an enzyme capable of converting sucrose into isomaltulose or trehalulose. Compared with sucrose, isomaltulose (Palatinose) not only has the physical and chemical properties and mouthfeel similar to those of sucrose, but also has the advantages of good acid stability, low hygroscopicity, high safety and the like, and has wide market application prospect in food. Meanwhile, isomaltulose is used as a novel sweetener, has the advantages of low sweetness (about half of the sweetness of sucrose), no decayed tooth, low calorie and the like, and is particularly suitable for patients with diabetes and obesity. In addition, the functional sugar alcohol can be used as a precursor for producing novel functional edible sugar alcohol.
At present, the research on the production method of isomaltulose mainly comprises four methods, namely an enzyme catalysis method, a microbial transformation method, a synthetic chemistry method and a plant transformation method. The isomaltulose produced by the chemical synthesis method is difficult and easily pollutes the environment. Although the medium Pueraria achieves the conversion of sucrose in plants to obtain isomaltulose, the method also has the problems of immature technology, low repetition rate, high environmental requirement, long period, high cost and the like. Thus, the biological method remains a method for mainly producing isomaltulose. In 1984, Nippon Xin Mitsui company successfully developed a special enzyme technology to industrially produce isomaltulose in large quantities. The prior art for preparing isomaltulose still mainly adopts microbial fermentation production, but the problems that sucrose and other miscellaneous sugars are difficult to separate, the purity of the obtained isomaltulose is low, the preparation process is complex, the production cost is high, a large amount of labor resources are consumed and the like exist in the preparation process.
With the rapid development of genetic engineering technology, sucrose isomerases from different sources are heterologously expressed in escherichia coli, and the yield of the enzymes is remarkably improved. The growing maturation of heterologous expression technologies solves the problem of low enzyme yields. Currently, the conversion rate for the production of isomaltulose by enzymatic conversion is between 65 and 92%. Wherein, the Liu Tong and the like successfully express sucrose isomerase derived from pantoea dispersa in Escherichia coli BL21, and the conversion rate of free enzyme after optimizing the enzyme conversion condition is the highest level reported by domestic and foreign documents and reaches 92.0%. The isomaltulose has high purity, downstream can obtain the high-purity isomaltulose only by a simple purification and crystallization process, and the generation difficulty and cost are obviously reduced.
However, neither wild-type sucrose isomerase nor the reported modified enzyme can achieve both good stability and high conversion rate. Poor stability will lead to difficulty in continuous industrial enzyme conversion of sucrose isomerase and storage and transportation of the enzyme, low conversion rate not only increases difficulty for development of downstream process, but also leads to waste of raw materials, both of which result in high cost of enzyme preparation of isomaltulose, and thus, the enzyme preparation cannot be applied in large scale. Therefore, the development of a sucrose isomerase mutant with both stability and conversion rate is urgently needed to be applied to the industrial production of isomaltulose in a large scale. Based on the purpose, the invention carries out mutation screening on the pantoea dispersata-source sucrose isomerase with high conversion rate, and further improves the activity and stability of the enzyme without reducing the conversion rate, so that the pantoea dispersata-source sucrose isomerase is more suitable for industrial application.
Disclosure of Invention
The invention aims to provide a sucrose isomerase mutant so as to enable the mutant to have higher activity and stability than wild sucrose isomerase, and increase continuous reaction batches of sucrose isomerase immobilized enzymes to meet industrial use requirements.
To achieve this object, in a basic embodiment, the present invention provides a sucrose isomerase mutant having a mutation in the amino acid sequence shown in SEQ ID NO.1 at an amino acid position including at least one of R434P and E273N.
Furthermore, the amino acid sequences of the two-point mutant of R434P and E273N are shown as SEQ ID NO. 2.
The second objective of the invention is to provide a polynucleotide encoding the sucrose isomerase mutant, so that the encoded sucrose isomerase mutant has higher activity and stability than the wild sucrose isomerase, and the continuous reaction batches of the sucrose isomerase immobilized enzyme are increased, thereby meeting the industrial use requirements.
To achieve this object, in a basic embodiment, the present invention provides a polynucleotide encoding the aforementioned sucrose isomerase mutant.
The third purpose of the invention is to provide the application of the sucrose isomerase mutant: used for catalyzing sucrose reaction to better prepare isomaltulose.
To achieve the object, in a basic embodiment, the present invention provides a use of a sucrose isomerase mutant for catalyzing a sucrose reaction with the sucrose isomerase mutant as described above in a reaction system to produce isomaltulose.
Further, in the reaction system, the enzyme activity of the sucrose isomerase mutant is 60-150U/g substrate sucrose.
Furthermore, in the reaction system, the concentration of sucrose is 30-70%.
Further, the reaction temperature is 25-40 ℃, and the reaction time is 120-180 min.
Further, the reaction pH was 5.5 to 7.0.
Further, the reaction stirring speed is 150-.
Further, the sucrose isomerase mutant is an immobilized sucrose isomerase mutant.
The sucrose isomerase mutant has the beneficial effects that the sucrose isomerase mutant has higher stability and fermentation activity than wild sucrose isomerase. Meanwhile, the sucrose conversion rate and the isomaltulose generation rate are improved, the impurity content is lower, and the prepared immobilized enzyme can continuously react in multiple batches, thereby meeting the requirements of industrial application.
The sucrose isomerase SIM from the disperse Pantoea is selected as a starting point, and compared with the SIMs from other sources, the sucrose isomerase SIM has the following advantages: the product inhibition is small, the catalytic efficiency is high, and the final product concentration is high. On the basis, the SIM is mutated by means of genetic engineering and enzyme engineering technology, and the obtained SIM-1 mutant has the advantages of improving enzyme fermentation activity by 3 times, improving thermal stability by 4 times, obviously improving immobilized enzyme activity and stability and the like compared with the SIM, and is more suitable for synthesis of isomaltulose because the sucrose conversion rate and the isomaltulose generation rate are improved and the impurity content is lower.
Drawings
FIG. 1 is a schematic diagram of isomaltulose synthesis.
Detailed Description
The present invention is further illustrated by, but is not limited to, the following examples.
The enzyme activity of the SIM and the mutant thereof is determined as follows.
Sucrose with a mass concentration of 15% was prepared as a substrate solution using 0.05mol/L of a citric acid-disodium hydrogen phosphate buffer solution with pH 6.5.
And (3) measuring the enzyme activity of the crude enzyme solution: adding 1ml of crude enzyme solution into 10ml of substrate solution at 30 ℃ and pH6.5, reacting for 10min, and calculating the enzyme activity according to the amount of isomaltulose produced.
Enzyme activity determination of the fermentation thalli: taking 50mL of zymocyte liquid, centrifuging at 12000r/min, removing supernatant, collecting thalli, re-suspending the thalli by using 50mL of normal saline, ultrasonically crushing (the ultrasonic time is 3s each time, the interval time is 2s, the ultrasonic frequency is 99 times, the ultrasonic power is 500W), taking 1mL of crushed liquid after completion, adding 10mL of reaction substrate, controlling the temperature at 30 ℃, stirring at the rotating speed of 150r/min, reacting for 10min, sampling 1mL after completion, and performing enzyme activity determination by using HPLC.
Enzyme activity determination of immobilized enzyme: accurately weighing 0.1g of immobilized enzyme, adding the immobilized enzyme into 10mL of reaction substrate for reaction, controlling the temperature at 30 ℃, stirring at the rotating speed of 150r/min, reacting for 10min, sampling 1mL of immobilized enzyme after the reaction is finished, and performing enzyme activity determination by using HPLC.
The HPLC measurement conditions were as follows:
liquid phase conditions: mobile phase: 75% acetonitrile in water
A chromatographic column: amide-805 um, 4.6 x 250mm
A detector: RID
Column temperature: 75 deg.C
Flow rate: 1.0ml/min
Sample introduction amount: 10 μ l
Peak time of each substance: sucrose: 13.844min
Isomaltulose: 14.929min
Glucose: 3.317min
Unit of enzyme activity: the amount of enzyme required to produce 1. mu. mol of isomaltulose per minute at a temperature of 30 ℃ and a pH of 6.5 is one unit (1U).
Example 1: construction of Pantoea dispersa-derived sucrose isomerase zymogen nuclear expression strain
Downloading an amino acid sequence (SEQ ID NO.1, corresponding to GenBank accession number: AAP57083.1) of Sucrose Isomerase (SIM) from Pantoea dispersa in GenBank, removing 1-21 signal peptide (MFLNGFKTVIALTMASSFYLA), and providing the signal peptide for Beijing Ongchoideae biotechnology Limited company to perform whole gene synthesis of coding nucleic acid (adopting preferred codon of Escherichia coli). The C-end of the synthetic gene is provided with a His label (the pET30a (+) vector is provided with the His label), the synthetic gene is constructed into a prokaryotic expression vector pET30a (+), and the restriction enzyme site of the prokaryotic expression vector is as follows: nde I at the 5 'end, Xho I at the 3' end. The constructed plasmid pET30a (+) -SIM is passed through CaCl2The heat shock transformation method is used for transforming the strain into an escherichia coli expression strain BL21(DE3), the strain is coated on an LB solid medium plate containing 50 mu g/ml Kanamycin, the plate is cultured overnight at 37 ℃, and a colony growing on the plate is the sucrose isomerase nuclear expression recombinant strain E.coli BL21(DE3)/pET30a (+) -SIM.
Carefully picking out a single colony of the sucrose isomerase zymogen nuclear expression recombinant strain in the LB solid culture medium plate by using a sterilized gun head, inoculating the single colony into a triangular flask containing 20mL of LB liquid culture medium, culturing at 37 ℃ at 200r/min, and shaking overnight. Inoculating the shake flask bacterial liquid into a triangular flask containing 100mL of TB liquid culture medium according to the inoculation amount of 1% the next day, carrying out shake culture at 37 ℃ at 220r/min, measuring the OD value of the culture solution every 1h, supplementing lactose with the final concentration of 1% (m/v) when the OD value of the culture solution is 1.5, continuously culturing at 25 ℃ at 220rpm for 4-6 h, and stopping culturing.
Example 2: purification and immobilization of Pantoea dispersa-derived sucrose isomerase
The fermentation broth obtained in example 1 was purified for protein using activated IDA Resin (His. bind Resin, Ni-charged, available from Annuan Biotech Ltd., Beijing) using His tag carried in the SIM recombinant protein, in the following manner: centrifuging the fermentation liquid for 10min at 4 ℃ and 10000r/min, discarding the supernatant, collecting the thallus, repeatedly washing the thallus twice with phosphate buffer solution (pH 7.5 and 0.1mol/L), centrifuging, and then concentrating the thallus by 5 times and suspending in 20ml of phosphate buffer solution (pH 7.5 and 0.1 mol/L). And (3) placing the treated bacterial liquid in ice water for ultrasonic crushing until the bacterial liquid is clarified, wherein the ultrasonic crushing conditions are as follows: work 2s, interval 5s, ultrasonic power 500W. And (3) placing the crushed lysate into a low-temperature high-speed centrifuge for centrifugation (12000rpm, 4 ℃ and 20min), and collecting supernatant to obtain crude protein. Loading the crude protein onto the activated IDA resin, performing gradient elution by using imidazole solution (10mM-300mM), performing real-time monitoring by using a protein chromatography system (Bio-Rad), and collecting the stable protein peak, namely the SIM recombinant protein purified protein, for preparing the immobilized enzyme.
The purified SIM recombinant protein is used for preparing immobilized enzyme, and the specific method comprises the following steps:
(1) activating an immobilized carrier: accurately measuring 30ml of 60% (m/v) glutaraldehyde and dipotassium hydrogen phosphate (K)2HPO4·3H2O)4.76g is added into 600ml deionized water, after dissolution, the volume is adjusted to 1000ml by deionized water, and the pH value is adjusted to 8.0 by phosphoric acid solution. An epoxy-based carrier ECEP (Resindions S.r.l. Italy) of 250g was put into the above solution and activated at 25 ℃ with low stirring for 2 hours, and the carrier was collected by filtration, washed 2 to 3 times with sterile deionized water and vacuum-filtered to dryness for use.
(2) Immobilization of SIM recombinant protein: diluting a certain amount of the purified SIM recombinant protein with a phosphate buffer solution (pH 6.5 and 0.5mol/L), adding 50g of the activated carrier, immobilizing for 16h at 25 ℃ and 120rpm, washing the obtained immobilized enzyme with the phosphate buffer solution (pH 6.5 and 0.02mol/L) for 3-5 times, and vacuum filtering to obtain the final immobilized enzyme product.
Example 3: construction of error-prone mutation library of SIM prokaryotic expression strain E.coli BL21(DE3)/pET30a (+) -SIM
pET30a (+) -SIM recombinant plasmid is used as PCR template, conventional T7F/R is used as universal primer (primer sequence: T7F: 5'-TAATACGACTCACTATAGGG-3' T7R: GCTAGTTATTGCTCAGCGG is shown in SEQ ID NO.3 and 4) to carry out error-prone PCR amplification on SIM gene, and Mg in a PCR amplification reaction system is adjusted2+、Mn2+dCTP and dTTP oligonucleotide concentration, so that the base mismatching rate of the mutant library is only two thousandth, namely ensuring that only 1 to 2 amino acids of one mutant are mutated.
Error-prone PCR reaction system:
error-prone PCR reaction conditions: pre-denaturation at 95 ℃ for 5 min; then denaturation at 94 ℃ for 30s, annealing at 56 ℃ for 1min, and extension at 72 ℃ for 1.5min for 25 cycles; finally, extension is carried out for 10min at 72 ℃.
And sampling 2 mu L of the error-prone PCR product, detecting the error-prone PCR product through agarose gel electrophoresis, and purifying the error-prone PCR product by using a PCR product purification kit after the error-prone PCR product is detected. The PCR purified product and the prokaryotic expression vector pET30a (+) were subjected to double digestion with Nde I and Xho I restriction enzymes at 37 ℃ respectively, and the digestion product was subjected to gel cutting and recovery (wherein the size of the recovered PCR purified product fragment is about 1700bp, and the size of the recovered vector pET30a (+) fragment is about 5400bp) followed by error-prone PCR: the prokaryotic expression vector pET30a (+) is 3: 1, and T4DNA ligase was added thereto and ligated overnight at 16 ℃. The next day, the ligation product is transferred into escherichia coli BL21(DE3) by an electric shock transformation method to construct engineering bacteria, and a random mutant library with large library capacity can be obtained.
Example 4: screening of error-prone mutation library of SIM prokaryotic expression strain E.coli BL21(DE3)/pET30a (+) -SIM
The screening principle is as follows:
based on the principle that a fibhlin reagent can react with reducing sugar to generate brick red precipitate, sucrose as a substrate is non-reducing sugar, and the product isomaltulose (reducing sugar) can be identified by using the fibhlin reagent.
The specific method comprises the following steps:
using the sterilized toothpicks, single colonies of the mutant library (1 single colony per toothpick) were carefully picked and inoculated into different wells of a 96-well cell culture plate (LB liquid medium containing 50. mu.g/ml kanamycin had been added to each well). The 96-well cell culture plates were incubated for 6 hours at 37 ℃ and 700rpm in a constant temperature shaker, then lactose was added to each well using an 8-channel pipette to a final concentration of 1% (m/v), and incubation was induced for 8 hours at 25 ℃ and 250 rpm. After induction culture is finished, a 96-hole cell culture plate is placed into an ultralow temperature refrigerator with the temperature of minus 86 ℃ for freezing for 2 hours, the cell culture plate is taken out and placed at the room temperature for half an hour and then 4000r/min, the cell culture plate is centrifuged at the temperature of 4 ℃ for 20 minutes, and 100 mu L of supernatant is taken out of each hole and is placed at the temperature of 47 ℃ for standing for 30 minutes. After warming up, 25. mu.L of the supernatant from each well was transferred to a new 96-well plate, and 50. mu.L of 50% sucrose (prepared with 0.05mol/L phosphate buffer, pH 6.5) was added thereto and reacted at 30 ℃ for 120 min. Then 50 μ l of film formazan were added: the mixed solution of ethyl-5: 1 was developed at 60 ℃ for 30 min. The color change was observed.
Through repeated mass screening verification (about 140000 clones), sequencing analysis and enzyme activity determination, an SIM mutant strain with 4-fold improved thermal stability and 3-fold improved zymolase activity, namely an SIM-1 expression strain, is obtained, and is subjected to two-point mutation of R434P and E273N.
Example 5: comparison of immobilized enzyme-catalyzed isomaltulose Synthesis reactions of the mutant strains and the control strains
The immobilized enzymes were prepared from SIM-1 and SIM respectively (same method as in example 2) to catalyze the isomaltulose synthesis reaction.
The reaction conditions are as follows: accurately weighing 50.0g of sucrose, dissolving with deionized water, fixing the volume to 100ml (the concentration is 50%), adding 0.2g of sucrose isomerase immobilized enzyme into each gram of sucrose, reacting at 30 ℃ and pH6.5 at 180r/min, sampling, detecting a liquid phase, performing suction filtration to obtain a reaction solution after the reaction is finished, top washing the immobilized enzyme with 100ml of 2mmol/L phosphate buffer solution with pH6.5, mixing the top washing solution into the reaction solution for the same volume, detecting the concentration, calculating the yield, and adding the top-washed enzyme into the next batch for reaction. The batch reaction cases of SIM-1 and SIM are shown in tables 1 and 2 below.
TABLE 1SIM-1 batch reaction
TABLE 2SIM batch reactions
The table results show that the activity of the mutant SIM-1 immobilized enzyme is improved by about 54 percent compared with the wild type SIM immobilized enzyme, the activity of the immobilized enzyme is integrally kept stable after 33 batches of reactions, the reaction time is stabilized at 2-2.5h, the activity of the SIM immobilized enzyme is obviously reduced after each batch of reactions, and the reaction time is also obviously prolonged. Obviously, compared with wild immobilized enzyme, the activity and stability of the mutant are obviously improved. In addition, the mutant SIM-1 immobilized enzyme can completely convert the sucrose, and the isomaltulose production rate reaches 96.98% at most. And the wild type SIM immobilized enzyme has a small amount of sucrose residues in the conversion process, and the highest isomaltulose production rate is 90.26%, which shows that the mutant has higher substrate conversion rate and product production rate compared with the wild type immobilized enzyme.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is intended to include such modifications and variations. The foregoing examples or embodiments are merely illustrative of the present invention, which may be embodied in other specific forms or in other specific forms without departing from the spirit or essential characteristics thereof. The described embodiments are, therefore, to be considered in all respects as illustrative and not restrictive. The scope of the invention should be indicated by the appended claims, and any changes that are equivalent to the intent and scope of the claims should be construed to be included therein.
Sequence listing
<110> Hunan Fulaige Biotechnology Ltd
<120> sucrose isomerase mutant and application thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 577
<212> PRT
<213> Pantoea dispersa
<400> 1
Ala Ser Pro Leu Thr Lys Pro Ser Thr Pro Ile Ala Ala Thr Asn Ile
1 5 10 15
Gln Lys Ser Ala Asp Phe Pro Ile Trp Trp Lys Gln Ala Val Phe Tyr
20 25 30
Gln Ile Tyr Pro Arg Ser Phe Lys Asp Ser Asn Gly Asp Gly Ile Gly
35 40 45
Asp Ile Pro Gly Ile Ile Glu Lys Leu Asp Tyr Leu Lys Met Leu Gly
50 55 60
Val Asp Ala Ile Trp Ile Asn Pro His Tyr Glu Ser Pro Asn Thr Asp
65 70 75 80
Asn Gly Tyr Asp Ile Ser Asp Tyr Arg Lys Ile Met Lys Glu Tyr Gly
85 90 95
Ser Met Ala Asp Phe Asp Arg Leu Val Ala Glu Met Asn Lys Arg Gly
100 105 110
Met Arg Leu Met Ile Asp Ile Val Ile Asn His Thr Ser Asp Arg His
115 120 125
Arg Trp Phe Val Gln Ser Arg Ser Gly Lys Asp Asn Pro Tyr Arg Asp
130 135 140
Tyr Tyr Phe Trp Arg Asp Gly Lys Gln Gly Gln Ala Pro Asn Asn Tyr
145 150 155 160
Pro Ser Phe Phe Gly Gly Ser Ala Trp Gln Leu Asp Lys Gln Thr Asp
165 170 175
Gln Tyr Tyr Leu His Tyr Phe Ala Pro Gln Gln Pro Asp Leu Asn Trp
180 185 190
Asp Asn Pro Lys Val Arg Ala Glu Leu Tyr Asp Ile Leu Arg Phe Trp
195 200 205
Leu Asp Lys Gly Val Ser Gly Leu Arg Phe Asp Thr Val Ala Thr Phe
210 215 220
Ser Lys Ile Pro Gly Phe Pro Asp Leu Ser Lys Ala Gln Leu Lys Asn
225 230 235 240
Phe Ala Glu Ala Tyr Thr Glu Gly Pro Asn Ile His Lys Tyr Ile His
245 250 255
Glu Met Asn Arg Gln Val Leu Ser Lys Tyr Asn Val Ala Thr Ala Gly
260 265 270
Glu Ile Phe Gly Val Pro Val Ser Ala Met Pro Asp Tyr Phe Asp Arg
275 280 285
Arg Arg Glu Glu Leu Asn Ile Ala Phe Thr Phe Asp Leu Ile Arg Leu
290 295 300
Asp Arg Tyr Pro Asp Gln Arg Trp Arg Arg Lys Pro Trp Thr Leu Ser
305 310 315 320
Gln Phe Arg Gln Val Ile Ser Gln Thr Asp Arg Ala Ala Gly Glu Phe
325 330 335
Gly Trp Asn Ala Phe Phe Leu Asp Asn His Asp Asn Pro Arg Gln Val
340 345 350
Ser His Phe Gly Asp Asp Ser Pro Gln Trp Arg Glu Arg Ser Ala Lys
355 360 365
Ala Leu Ala Thr Leu Leu Leu Thr Gln Arg Ala Thr Pro Phe Ile Phe
370 375 380
Gln Gly Ala Glu Leu Gly Met Thr Asn Tyr Pro Phe Lys Asn Ile Glu
385 390 395 400
Glu Phe Asp Asp Ile Glu Val Lys Gly Phe Trp Asn Asp Tyr Val Ala
405 410 415
Ser Gly Lys Val Asn Ala Ala Glu Phe Leu Gln Glu Val Arg Met Thr
420 425 430
Ser Arg Asp Asn Ser Arg Thr Pro Met Gln Trp Asn Asp Ser Val Asn
435 440 445
Ala Gly Phe Thr Gln Gly Lys Pro Trp Phe His Leu Asn Pro Asn Tyr
450 455 460
Lys Gln Ile Asn Ala Ala Arg Glu Val Asn Lys Pro Asp Ser Val Phe
465 470 475 480
Ser Tyr Tyr Arg Gln Leu Ile Asn Leu Arg His Gln Ile Pro Ala Leu
485 490 495
Thr Ser Gly Glu Tyr Arg Asp Leu Asp Pro Gln Asn Asn Gln Val Tyr
500 505 510
Ala Tyr Thr Arg Ile Leu Asp Asn Glu Lys Tyr Leu Val Val Val Asn
515 520 525
Phe Lys Pro Glu Gln Leu His Tyr Ala Leu Pro Asp Asn Leu Thr Ile
530 535 540
Ala Ser Ser Leu Leu Glu Asn Val His Gln Pro Ser Leu Gln Glu Asn
545 550 555 560
Ala Ser Thr Leu Thr Leu Ala Pro Trp Gln Ala Gly Ile Tyr Lys Leu
565 570 575
Asn
<210> 2
<211> 577
<212> PRT
<213> Pantoea dispersa (Pantoea dispersa)
<400> 2
Ala Ser Pro Leu Thr Lys Pro Ser Thr Pro Ile Ala Ala Thr Asn Ile
1 5 10 15
Gln Lys Ser Ala Asp Phe Pro Ile Trp Trp Lys Gln Ala Val Phe Tyr
20 25 30
Gln Ile Tyr Pro Arg Ser Phe Lys Asp Ser Asn Gly Asp Gly Ile Gly
35 40 45
Asp Ile Pro Gly Ile Ile Glu Lys Leu Asp Tyr Leu Lys Met Leu Gly
50 55 60
Val Asp Ala Ile Trp Ile Asn Pro His Tyr Glu Ser Pro Asn Thr Asp
65 70 75 80
Asn Gly Tyr Asp Ile Ser Asp Tyr Arg Lys Ile Met Lys Glu Tyr Gly
85 90 95
Ser Met Ala Asp Phe Asp Arg Leu Val Ala Glu Met Asn Lys Arg Gly
100 105 110
Met Arg Leu Met Ile Asp Ile Val Ile Asn His Thr Ser Asp Arg His
115 120 125
Arg Trp Phe Val Gln Ser Arg Ser Gly Lys Asp Asn Pro Tyr Arg Asp
130 135 140
Tyr Tyr Phe Trp Arg Asp Gly Lys Gln Gly Gln Ala Pro Asn Asn Tyr
145 150 155 160
Pro Ser Phe Phe Gly Gly Ser Ala Trp Gln Leu Asp Lys Gln Thr Asp
165 170 175
Gln Tyr Tyr Leu His Tyr Phe Ala Pro Gln Gln Pro Asp Leu Asn Trp
180 185 190
Asp Asn Pro Lys Val Arg Ala Glu Leu Tyr Asp Ile Leu Arg Phe Trp
195 200 205
Leu Asp Lys Gly Val Ser Gly Leu Arg Phe Asp Thr Val Ala Thr Phe
210 215 220
Ser Lys Ile Pro Gly Phe Pro Asp Leu Ser Lys Ala Gln Leu Lys Asn
225 230 235 240
Phe Ala Glu Ala Tyr Thr Glu Gly Pro Asn Ile His Lys Tyr Ile His
245 250 255
Glu Met Asn Arg Gln Val Leu Ser Lys Tyr Asn Val Ala Thr Ala Gly
260 265 270
Asn Ile Phe Gly Val Pro Val Ser Ala Met Pro Asp Tyr Phe Asp Arg
275 280 285
Arg Arg Glu Glu Leu Asn Ile Ala Phe Thr Phe Asp Leu Ile Arg Leu
290 295 300
Asp Arg Tyr Pro Asp Gln Arg Trp Arg Arg Lys Pro Trp Thr Leu Ser
305 310 315 320
Gln Phe Arg Gln Val Ile Ser Gln Thr Asp Arg Ala Ala Gly Glu Phe
325 330 335
Gly Trp Asn Ala Phe Phe Leu Asp Asn His Asp Asn Pro Arg Gln Val
340 345 350
Ser His Phe Gly Asp Asp Ser Pro Gln Trp Arg Glu Arg Ser Ala Lys
355 360 365
Ala Leu Ala Thr Leu Leu Leu Thr Gln Arg Ala Thr Pro Phe Ile Phe
370 375 380
Gln Gly Ala Glu Leu Gly Met Thr Asn Tyr Pro Phe Lys Asn Ile Glu
385 390 395 400
Glu Phe Asp Asp Ile Glu Val Lys Gly Phe Trp Asn Asp Tyr Val Ala
405 410 415
Ser Gly Lys Val Asn Ala Ala Glu Phe Leu Gln Glu Val Arg Met Thr
420 425 430
Ser Pro Asp Asn Ser Arg Thr Pro Met Gln Trp Asn Asp Ser Val Asn
435 440 445
Ala Gly Phe Thr Gln Gly Lys Pro Trp Phe His Leu Asn Pro Asn Tyr
450 455 460
Lys Gln Ile Asn Ala Ala Arg Glu Val Asn Lys Pro Asp Ser Val Phe
465 470 475 480
Ser Tyr Tyr Arg Gln Leu Ile Asn Leu Arg His Gln Ile Pro Ala Leu
485 490 495
Thr Ser Gly Glu Tyr Arg Asp Leu Asp Pro Gln Asn Asn Gln Val Tyr
500 505 510
Ala Tyr Thr Arg Ile Leu Asp Asn Glu Lys Tyr Leu Val Val Val Asn
515 520 525
Phe Lys Pro Glu Gln Leu His Tyr Ala Leu Pro Asp Asn Leu Thr Ile
530 535 540
Ala Ser Ser Leu Leu Glu Asn Val His Gln Pro Ser Leu Gln Glu Asn
545 550 555 560
Ala Ser Thr Leu Thr Leu Ala Pro Trp Gln Ala Gly Ile Tyr Lys Leu
565 570 575
Asn
<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
taatacgact cactataggg 20
<210> 4
<211> 19
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
gctagttatt gctcagcgg 19
Claims (9)
1. A sucrose isomerase mutant, characterized in that: the amino acid sequence shown in SEQ ID NO.1 is mutated, the mutated amino acid sites are R434P and E273N, and the amino acid sequences of the two-point mutant of R434P and E273N are shown in SEQ ID NO. 2.
2. A nucleotide encoding the sucrose isomerase mutant of claim 1.
3. Use of a sucrose isomerase mutant as claimed in claim 1 wherein: used for catalyzing sucrose reaction to prepare isomaltulose.
4. Use according to claim 3, characterized in that: in the reaction system, the enzyme activity of the sucrose isomerase mutant is 60-150U/g substrate sucrose.
5. Use according to claim 3, characterized in that: in the reaction system, the concentration of the sucrose is 30-70%.
6. Use according to claim 3, characterized in that: the reaction temperature is 25-40 ℃, and the reaction time is 120-180 min.
7. Use according to claim 3, characterized in that: the reaction pH is 5.5-7.0.
8. Use according to claim 3, characterized in that: the reaction stirring speed is 150-200 r/min.
9. Use according to claim 3, characterized in that: the sucrose isomerase mutant is an immobilized sucrose isomerase mutant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110868362.2A CN113481189B (en) | 2021-07-30 | 2021-07-30 | Sucrose isomerase mutant and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110868362.2A CN113481189B (en) | 2021-07-30 | 2021-07-30 | Sucrose isomerase mutant and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113481189A CN113481189A (en) | 2021-10-08 |
| CN113481189B true CN113481189B (en) | 2022-06-24 |
Family
ID=77943578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110868362.2A Active CN113481189B (en) | 2021-07-30 | 2021-07-30 | Sucrose isomerase mutant and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113481189B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114134136B (en) * | 2021-11-30 | 2023-09-08 | 南京诺云生物科技有限公司 | Rapid preparation method of isomaltulose under high reaction concentration and sucrose isomerase thereof |
| CN114085824B (en) * | 2021-12-08 | 2023-02-24 | 广西科学院 | Sucrose isomerase mutant, construction method and application thereof, recombinant expression vector and recombinant bacterium |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2681324A1 (en) * | 2011-03-03 | 2014-01-08 | Targeted Growth, Inc. | Expression of isomers of sucrose increases seed weight, seed number and/or seed size |
| CN104059901A (en) * | 2014-05-06 | 2014-09-24 | 江南大学 | Sucrose isomerase mutants with improved heat stability and secretion efficiency and preparation method thereof |
| CN104762286A (en) * | 2015-03-30 | 2015-07-08 | 江南大学 | Sucrose isomerase mutant with improved thermal stability and catalytic efficiency |
| KR20160014818A (en) * | 2014-07-29 | 2016-02-12 | 경희대학교 산학협력단 | Mutated sucrose isomerase and process for preparing the same |
| CN105483107A (en) * | 2015-12-31 | 2016-04-13 | 天津科技大学 | Sucrose isomerase mutant and method for producing isomaltulose |
| CN106367377A (en) * | 2016-09-22 | 2017-02-01 | 江南大学 | Immobilization method of sucrose isomerase |
| CN107189998A (en) * | 2017-04-19 | 2017-09-22 | 威尔金有限责任公司 | A kind of sucrose isomerase enzyme mutant and its application |
| CN111087476A (en) * | 2019-12-31 | 2020-05-01 | 天津科技大学 | Double-signal peptide for improving expression quantity of foreign protein and construction method and application thereof |
| WO2020099425A1 (en) * | 2018-11-14 | 2020-05-22 | Evonik Operations Gmbh | Isomaltulose production |
| CN113151237A (en) * | 2021-05-21 | 2021-07-23 | 江南大学 | Sucrose isomerase mutant with improved stability and construction method thereof |
| CN113174385A (en) * | 2021-04-13 | 2021-07-27 | 苏州朗邦营养科技有限公司 | Sucrose isomerase mutant with high activity and high conversion rate and application thereof |
-
2021
- 2021-07-30 CN CN202110868362.2A patent/CN113481189B/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2681324A1 (en) * | 2011-03-03 | 2014-01-08 | Targeted Growth, Inc. | Expression of isomers of sucrose increases seed weight, seed number and/or seed size |
| CN104059901A (en) * | 2014-05-06 | 2014-09-24 | 江南大学 | Sucrose isomerase mutants with improved heat stability and secretion efficiency and preparation method thereof |
| KR20160014818A (en) * | 2014-07-29 | 2016-02-12 | 경희대학교 산학협력단 | Mutated sucrose isomerase and process for preparing the same |
| CN104762286A (en) * | 2015-03-30 | 2015-07-08 | 江南大学 | Sucrose isomerase mutant with improved thermal stability and catalytic efficiency |
| CN105483107A (en) * | 2015-12-31 | 2016-04-13 | 天津科技大学 | Sucrose isomerase mutant and method for producing isomaltulose |
| CN106367377A (en) * | 2016-09-22 | 2017-02-01 | 江南大学 | Immobilization method of sucrose isomerase |
| CN107189998A (en) * | 2017-04-19 | 2017-09-22 | 威尔金有限责任公司 | A kind of sucrose isomerase enzyme mutant and its application |
| WO2020099425A1 (en) * | 2018-11-14 | 2020-05-22 | Evonik Operations Gmbh | Isomaltulose production |
| CN111087476A (en) * | 2019-12-31 | 2020-05-01 | 天津科技大学 | Double-signal peptide for improving expression quantity of foreign protein and construction method and application thereof |
| CN113174385A (en) * | 2021-04-13 | 2021-07-27 | 苏州朗邦营养科技有限公司 | Sucrose isomerase mutant with high activity and high conversion rate and application thereof |
| CN113151237A (en) * | 2021-05-21 | 2021-07-23 | 江南大学 | Sucrose isomerase mutant with improved stability and construction method thereof |
Non-Patent Citations (3)
| Title |
|---|
| Hyeon Cheol Lee等.Isomaltose Production by Modification of the Fructose-Binding Site on the Basis of the Predicted Structure of Sucrose Isomerase from "Protaminobacter rubrum".《APPL.ENVIRON.MICROBIOL.》.2008,第74卷(第16期),第5183-5194页. * |
| Wu Luguang等.Characterization of the Highly Efficient Sucrose Isomerase from Pantoea dispersa UQ68J and Cloning of the Sucrose Isomerase Gene.《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》.2005,第71卷(第3期),第1581-1590页. * |
| 唐文竹等.蔗糖异构酶催化生产异麦芽酮糖研究进展.《微生物学通报》.2012,第39卷(第9期),第1314-1322页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113481189A (en) | 2021-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113481189B (en) | Sucrose isomerase mutant and application thereof | |
| CN108018278B (en) | D-psicose 3-epimerase mutant with improved catalytic efficiency | |
| CN113528480B (en) | Alpha-1, 2-fucosyltransferase mutant and construction method and application thereof | |
| CN112251428B (en) | Glutamic acid decarboxylase mutant and application thereof in production of gamma-aminobutyric acid | |
| CN113174385B (en) | Sucrose isomerase mutant with high activity and high conversion rate and application thereof | |
| CN111235126B (en) | S-adenosylmethionine synthetase mutant and preparation method using same | |
| JP2022544085A (en) | Psicose 3-epimerase mutant, genetically engineered fungus for expressing same, immobilized enzyme and immobilization method thereof | |
| CN112831489A (en) | Psicose 3-epimerase immobilized enzyme, and immobilization method and application thereof | |
| CN110862980B (en) | D-psicose3-epimerase mutant and application thereof | |
| CN105087533A (en) | Mutant of penicillin G acylase (PGA) and preparation method and application of mutant | |
| CN110904088B (en) | High-temperature-resistant D-psicose3-epimerase, mutant and application thereof | |
| CN111206009B (en) | Genetic engineering bacterium for high yield of D-psicose and application thereof | |
| CN111394410B (en) | High-catalytic-activity neuraminic acid synthase and application thereof | |
| CN111455003A (en) | Method for preparing D-psicose from microalgae | |
| CN107400667B (en) | Immobilization method of cell containing recombinant high-temperature-resistant glucose isomerase | |
| CN113584008B (en) | Penicillin G acylase mutant and application thereof | |
| CN106119235B (en) | A kind of DPE and its application from bulkholderia cepasea | |
| CN109161540B (en) | Penicillin V acylase mutant, coding sequence, recombinant expression vector, genetic engineering bacterium and application | |
| CN114107158A (en) | Recombinant corynebacterium glutamicum capable of producing high-purity isomaltulose in high yield and application of recombinant corynebacterium glutamicum | |
| CN113151240A (en) | Glucose isomerase, mutant, coding gene and application thereof | |
| CN110904087B (en) | L-arabinose epimerase mutant and application thereof | |
| CN111057698B (en) | L-arabinose isomerase, mutant and application thereof | |
| CN118308329B (en) | Beta-N-acetaminophen hexosaminidase D297K and application thereof | |
| CN117802080A (en) | C3-epimerase mutant and application thereof in production of D-psicose | |
| CN117625585B (en) | Bifunctional enzyme NagEA and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A sucrose isomerase mutant and its application Granted publication date: 20220624 Pledgee: Changsha Bank city branch of Limited by Share Ltd. Pledgor: HUNAN FLAG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2024980012003 |